In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. This report studies the Drug Discovery Technologies market.
Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.
In 2018, the global Drug Discovery Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Drug Discovery Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Discovery Technologies development in United States, Europe and China.
The key players covered in this study
Agilent Technologies, Inc
Abbott Laboratories, Inc.
GE Healthcare Ltd.
Albany Molecular Research Inc.
Affymetrix Inc.
Arqule Inc.
Luminex Corporation
Bayer Healthcare AG
Novartis AG
Astrazeneca plc
Market segment by Type, the product can be split into
Biochips
High Throughput Screening
Pharmacogenomics
Genomics
Bioanalytical Instruments
Bioinformatics
Nanotechnology
Others (RNAi, combinatorial chemistry)
Market segment by Application, split into
Biopharmaceutical Companies
Pharmaceutical Companies
Research Institutes
Biotech Companies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Drug Discovery Technologies status, future forecast, growth opportunity, key market and key players.
To present the Drug Discovery Technologies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Drug Discovery Technologies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Drug Discovery Technologies . Industry analysis & Market Report on Drug Discovery Technologies is a syndicated market report, published as Global Drug Discovery Technologies Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Drug Discovery Technologies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.